Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS: ELTP · Delayed Price · USD
0.153
+0.001 (0.43%)
Mar 27, 2024, 3:58 PM EDT - Market closed
Elite Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 1998 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 7.83 | 8.54 | 3.19 | 1.13 | 2.28 | 7.18 | 10.59 | 11.51 | 7.46 | 6.94 | Upgrade
|
Cash & Cash Equivalents | 7.83 | 8.54 | 3.19 | 1.13 | 2.28 | 7.18 | 10.59 | 11.51 | 7.46 | 6.94 | Upgrade
|
Cash Growth | -8.24% | 167.33% | 182.11% | -50.31% | -68.27% | -32.24% | -7.97% | 54.23% | 7.53% | 1781.12% | Upgrade
|
Receivables | 3.09 | 3.06 | 3.5 | 4.11 | 1.32 | 0.68 | 0.93 | 1.53 | 1.45 | 0.73 | Upgrade
|
Inventory | 9.55 | 6.74 | 5.01 | 4.14 | 4.52 | 4.9 | 6.42 | 3.29 | 3.03 | 1.93 | Upgrade
|
Other Current Assets | 1.03 | 0.53 | 0.49 | 0.87 | 0.74 | 0.95 | 0.47 | 0.38 | 0.39 | 0.32 | Upgrade
|
Total Current Assets | 21.51 | 18.86 | 12.19 | 10.25 | 8.86 | 13.7 | 18.41 | 16.71 | 12.33 | 9.92 | Upgrade
|
Property, Plant & Equipment | 10.44 | 6.98 | 6.86 | 7.59 | 8.44 | 8.99 | 9.04 | 8.11 | 6.4 | 4.2 | Upgrade
|
Long-Term Investments | 0.02 | 0.41 | 0.41 | 0.4 | 0.4 | 0 | 0 | 0 | 0 | 3.33 | Upgrade
|
Intangible Assets | 6.34 | 6.63 | 6.63 | 6.63 | 6.63 | 7.71 | 6.42 | 6.41 | 6.38 | 6.35 | Upgrade
|
Other Long-Term Assets | 2.58 | 2.26 | 0.09 | 0.08 | 0.07 | 0.47 | 0.44 | 0.64 | 0.81 | 0.51 | Upgrade
|
Total Long-Term Assets | 19.39 | 16.29 | 13.99 | 14.71 | 15.55 | 17.18 | 15.9 | 15.16 | 13.59 | 14.39 | Upgrade
|
Total Assets | 40.9 | 35.15 | 26.19 | 24.96 | 24.4 | 30.88 | 34.31 | 31.88 | 25.92 | 24.32 | Upgrade
|
Accounts Payable | 2.45 | 1.43 | 0.93 | 1.58 | 1.38 | 1.66 | 1.05 | 1.8 | 0 | 2.21 | Upgrade
|
Deferred Revenue | 0.01 | 0.01 | 0.01 | 0.18 | 1.16 | 1.01 | 1.01 | 1.01 | 0.01 | 0.01 | Upgrade
|
Current Debt | 0.33 | 0.56 | 0.6 | 2.06 | 0.65 | 0.65 | 0.49 | 1.28 | 1.06 | 3.93 | Upgrade
|
Other Current Liabilities | 5.05 | 4.69 | 4.27 | 4.82 | 3.71 | 1.79 | 0.79 | 0.56 | 4 | 0 | Upgrade
|
Total Current Liabilities | 7.83 | 6.69 | 5.81 | 8.64 | 6.91 | 5.11 | 3.34 | 4.65 | 5.07 | 6.16 | Upgrade
|
Long-Term Debt | 3.56 | 2.22 | 1.78 | 1.97 | 3.33 | 3.33 | 2.16 | 2.37 | 2.07 | 0.09 | Upgrade
|
Other Long-Term Liabilities | 0.54 | 1.01 | 2.45 | 3.69 | 2.77 | 3.96 | 3.14 | 13.69 | 53.52 | 99.27 | Upgrade
|
Total Long-Term Liabilities | 4.1 | 3.23 | 4.23 | 5.66 | 6.1 | 7.29 | 5.3 | 16.06 | 55.58 | 99.36 | Upgrade
|
Total Liabilities | 11.94 | 9.93 | 10.04 | 14.3 | 13.01 | 12.41 | 8.65 | 20.72 | 60.65 | 105.52 | Upgrade
|
Total Debt | 3.89 | 2.78 | 2.38 | 4.03 | 3.98 | 3.99 | 2.65 | 3.65 | 3.12 | 4.02 | Upgrade
|
Debt Growth | 39.75% | 16.95% | -40.95% | 1.20% | -0.14% | 50.49% | -27.38% | 16.77% | -22.31% | 0.72% | Upgrade
|
Common Stock | 1.01 | 1.01 | 1.01 | 0.84 | 0.82 | 0.8 | 0.93 | 0.71 | 0.63 | 0.56 | Upgrade
|
Retained Earnings | -136.5 | -140.06 | -148.96 | -154.05 | -151.81 | -142.53 | -138.85 | -142.66 | -196.08 | -225.01 | Upgrade
|
Comprehensive Income | 0 | 0 | 0 | 0 | -9.65 | -8.41 | -7.43 | -6.73 | -6.07 | -5.51 | Upgrade
|
Shareholders' Equity | 28.96 | 25.22 | 16.15 | 10.66 | 11.4 | 18.48 | 25.66 | 11.16 | -34.73 | -81.2 | Upgrade
|
Total Liabilities and Equity | 40.9 | 35.15 | 26.19 | 24.96 | 24.4 | 30.88 | 34.31 | 31.88 | 25.92 | 24.32 | Upgrade
|
Net Cash / Debt | 3.94 | 5.75 | 0.81 | -2.9 | -1.7 | 3.19 | 7.95 | 7.87 | 4.34 | 2.92 | Upgrade
|
Net Cash / Debt Growth | -31.44% | 606.63% | - | - | - | -59.81% | 1.03% | 81.18% | 48.58% | - | Upgrade
|
Net Cash Per Share | 0.00 | 0.01 | 0.00 | -0.00 | -0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Working Capital | 13.68 | 12.17 | 6.38 | 1.61 | 1.95 | 8.59 | 15.07 | 12.06 | 7.26 | 3.76 | Upgrade
|
Book Value Per Share | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | 0.03 | 0.02 | -0.06 | -0.18 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.